[English] 日本語
Yorodumi- PDB-6nro: Human parainfluenza virus type 3 fusion protein N-terminal heptad... -
+
Open data
-
Basic information
| Entry | Database: PDB / ID: 6nro | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Human parainfluenza virus type 3 fusion protein N-terminal heptad repeat domain+VIQKI | |||||||||
Components |
| |||||||||
Keywords | ANTIVIRAL PROTEIN / Fusion protein / fusion inhibitor / six-helix bundle | |||||||||
| Function / homology | Function and homology informationfusion of virus membrane with host plasma membrane / viral envelope / symbiont entry into host cell / host cell plasma membrane / virion membrane / membrane / plasma membrane Similarity search - Function | |||||||||
| Biological species | Human parainfluenza virus 3 | |||||||||
| Method | X-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.75 Å | |||||||||
Authors | Outlaw, V.K. / Kreitler, D.F. / Gellman, S.H. | |||||||||
| Funding support | United States, 2items
| |||||||||
Citation | Journal: J.Am.Chem.Soc. / Year: 2019Title: Dual Inhibition of Human Parainfluenza Type 3 and Respiratory Syncytial Virus Infectivity with a Single Agent. Authors: Outlaw, V.K. / Bottom-Tanzer, S. / Kreitler, D.F. / Gellman, S.H. / Porotto, M. / Moscona, A. | |||||||||
| History |
|
-
Structure visualization
| Structure viewer | Molecule: Molmil Jmol/JSmol |
|---|
-
Downloads & links
-
Download
| PDBx/mmCIF format | 6nro.cif.gz | 156.8 KB | Display | PDBx/mmCIF format |
|---|---|---|---|---|
| PDB format | pdb6nro.ent.gz | 127.3 KB | Display | PDB format |
| PDBx/mmJSON format | 6nro.json.gz | Tree view | PDBx/mmJSON format | |
| Others | Other downloads |
-Validation report
| Summary document | 6nro_validation.pdf.gz | 465.6 KB | Display | wwPDB validaton report |
|---|---|---|---|---|
| Full document | 6nro_full_validation.pdf.gz | 466 KB | Display | |
| Data in XML | 6nro_validation.xml.gz | 11.6 KB | Display | |
| Data in CIF | 6nro_validation.cif.gz | 16 KB | Display | |
| Arichive directory | https://data.pdbj.org/pub/pdb/validation_reports/nr/6nro ftp://data.pdbj.org/pub/pdb/validation_reports/nr/6nro | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 6ntxC ![]() 6nyxC ![]() 1ztmS S: Starting model for refinement C: citing same article ( |
|---|---|
| Similar structure data |
-
Links
-
Assembly
| Deposited unit | ![]()
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 |
| ||||||||
| Unit cell |
|
-
Components
| #1: Protein | Mass: 5656.473 Da / Num. of mol.: 3 / Fragment: UNP residues 139-189 / Source method: obtained synthetically Details: This compound is derived from residues 139-189 of the HPIV3 fusion glycoprotein. It is acetylated at the N-terminus and amidated at the C-terminus. Source: (synth.) Human parainfluenza virus 3 / References: UniProt: A0A1V0E102, UniProt: P06828*PLUS#2: Protein/peptide | Mass: 4194.895 Da / Num. of mol.: 3 / Fragment: 449-484 / Mutation: E459V, A463I, D466Q, Q479K, K480I / Source method: obtained synthetically Details: VIQKI is a synthetic peptide derived from residues 449-484 of the HPIV3 fusion glycoprotein C-terminal heptad repeat domain with substitutions E459V, A463I, D466Q, Q479K and K480I. It is ...Details: VIQKI is a synthetic peptide derived from residues 449-484 of the HPIV3 fusion glycoprotein C-terminal heptad repeat domain with substitutions E459V, A463I, D466Q, Q479K and K480I. It is acetylated at the N-terminus and amidated at the C-terminus. Source: (synth.) Human parainfluenza virus 3 / References: UniProt: A0A023PHT3, UniProt: P06828*PLUS#3: Chemical | ChemComp-CA / | #4: Chemical | ChemComp-PEG / | #5: Water | ChemComp-HOH / | Has protein modification | Y | |
|---|
-Experimental details
-Experiment
| Experiment | Method: X-RAY DIFFRACTION / Number of used crystals: 1 |
|---|
-
Sample preparation
| Crystal | Density Matthews: 1.88 Å3/Da / Density % sol: 34.56 % |
|---|---|
| Crystal grow | Temperature: 298 K / Method: vapor diffusion, hanging drop / pH: 6.5 Details: 30 mM NaF, 30 mM NaBr, 30 mM NaI, 20% (v/v) PEG 500 MME, 10% (w/v) PEG 20000 in 100 mM imidazole/MES monohydrate buffer (pH 6.5)20% (v/v) PEG 500 MME, 10% (w/v) PEG 20000 in 100 mM ...Details: 30 mM NaF, 30 mM NaBr, 30 mM NaI, 20% (v/v) PEG 500 MME, 10% (w/v) PEG 20000 in 100 mM imidazole/MES monohydrate buffer (pH 6.5)20% (v/v) PEG 500 MME, 10% (w/v) PEG 20000 in 100 mM imidazole/MES monohydrate buffer (pH 6.5) |
-Data collection
| Diffraction | Mean temperature: 100 K / Serial crystal experiment: N |
|---|---|
| Diffraction source | Source: SYNCHROTRON / Site: APS / Beamline: 23-ID-B / Wavelength: 1.033 Å |
| Detector | Type: DECTRIS EIGER X 16M / Detector: PIXEL / Date: Mar 25, 2018 |
| Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
| Radiation wavelength | Wavelength: 1.033 Å / Relative weight: 1 |
| Reflection | Resolution: 1.75→39.293 Å / Num. obs: 22158 / % possible obs: 99.5 % / Redundancy: 6.6 % / Biso Wilson estimate: 36.72 Å2 / CC1/2: 1 / Rpim(I) all: 0.01925 / Rrim(I) all: 0.04893 / Rsym value: 0.04488 / Net I/σ(I): 18.26 |
| Reflection shell | Resolution: 1.75→1.813 Å / Redundancy: 6.5 % / Mean I/σ(I) obs: 1.45 / Num. unique obs: 2189 / CC1/2: 0.726 / Rpim(I) all: 0.48 / Rrim(I) all: 1.238 / Rsym value: 1.139 / % possible all: 99.95 |
-
Processing
| Software |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Refinement | Method to determine structure: MOLECULAR REPLACEMENTStarting model: 1ZTM Resolution: 1.75→39.293 Å / SU ML: 0.25 / Cross valid method: THROUGHOUT / σ(F): 1.34 / Phase error: 28.83
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Solvent computation | Shrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Displacement parameters | Biso max: 305.93 Å2 / Biso mean: 54.3386 Å2 / Biso min: 26.48 Å2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement step | Cycle: final / Resolution: 1.75→39.293 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| LS refinement shell | Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / Total num. of bins used: 14
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS params. | Method: refined / Origin x: -6.7167 Å / Origin y: -8.1854 Å / Origin z: -20.1981 Å
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Refinement TLS group |
|
Movie
Controller
About Yorodumi



Human parainfluenza virus 3
X-RAY DIFFRACTION
United States, 2items
Citation












PDBj





